Current research investigating potential advantages beyond glycaemic regulation and weight reduction, including impacts on non-alcoholic fatty liver disease, cardiovascular outcomes, and renal protection, may broaden the therapeutic uses of these medicines
Individuals with a history of recurrent UTIs, women, the elderly, and those with compromised immune systems may be at higher risk and should take additional precautions
If the FDA verifies that a corrective action has been taken, it may issue a close-out letter
Toth, Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, plays a significant role in regulating appetite and food intake
Cognition in healthy, older adults may also be improved with supplementation that improves glutathione levels (10)